MedPath

Therapeutic efficacy study of artemether-lumefantrine and artesunate-amodiaquine in the treatment of uncomplicated Plasmodium falciparum malaria at two sentinel sites in Togo

Not Applicable
Recruiting
Conditions
uncomplicated falciparum malaria
Infection - Studies of infection and infectious agents
Registration Number
ACTRN12612001039875
Lead Sponsor
Ministere de la Sante du Togo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
450
Inclusion Criteria

age between 6 and 59 months
microscopically confirmed monoinfection with P falciparum
parasitemia (asexual forms) between 2000 and 200 000 per microliter
fever (body temperature of 37.5 C or greater)
able to swallow medication
able to comply with protocol assessment schedule

Exclusion Criteria

clinical signs and symptoms of severe malaria
infection with another Plasmodium species or co-infection
severe malnutrition
fever due to other diseases

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath